Adapting US Practice to Patenting Pharmaceuticals in China
No-Poach and Non-Solicitation Agreements: Naked Antitrust Violations or Legitimate Business Arrangements
Using IP as Collateral: Locking ‘Trap Doors’ and Other Advanced IP Issues